Gadoxetic acid
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 2-[[2-[bis(2-oxido-2-oxoethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(2-oxido-2-oxoethyl)amino]ethyl]amino]acetate; gadolinium(+3) cation | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 135326-11-3  |
| ATC code | V08CA10 |
| PubChem | CID 219084 |
| UNII | 3QJA87N40S  |
| KEGG | D08008 |
| ChEMBL | CHEMBL1201769 |
| Chemical data | |
| Formula | C23H30GdN3O11 |
| Mol. mass | 681.75 g/mol |
 (what is this?) (verify) |
|
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United states by Bayer HealthCare Pharmaceuticals.[1]
[edit] References
- ^ "Eovist - Homepage". http://imaging.bayerhealthcare.com/html/eovist/index.html. Retrieved 2009-03-22.
|
||||||||||||||||||||||||||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
